J. Lotem et L. Sachs, A MUTANT P53 ANTAGONIZES THE DEREGULATED C-MYC-MEDIATED ENHANCEMENT OF APOPTOSIS AND DECREASE IN LEUKEMOGENICITY, Proceedings of the National Academy of Sciences of the United Statesof America, 92(21), 1995, pp. 9672-9676
Myeloid leukemic M1 cells that do not express p53 and transfected M1 c
lones that constitutively express the [Val(135)]p53 mutant or deregula
ted c-myc or coexpressing both genes grew autonomously in culture with
a similar growth rate and cloning efficiency. Expression of deregulat
ed c-myc in M1 leukemic cells enhanced susceptibility to induction of
apoptotic cell death and resulted in a reduced leukemogenicity when in
jected into isologous mice. Expression of the [Val(135)]p53 mutant did
not change cell susceptibility to induction of apoptosis or leukemoge
nicity, but expression of this mutant p53 suppressed the effects of de
regulated c-myc on these properties. The results indicate that the [Va
l(135)]p53 mutant can show a gain of function for susceptibility to ap
optosis and leukemogenicity in leukemic cells with deregulated c-myc a
nd, thus, enhance tumor development.